Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.59
-0.14 (-1.44%)
At close: Feb 13, 2026

HKG:2566 Revenue

Hangzhou Jiuyuan Genetic Biopharmaceutical had revenue of 638.78M CNY in the half year ending June 30, 2025, a decrease of -3.71%. This brings the company's revenue in the last twelve months to 1.31B, down -1.56% year-over-year. In the year 2024, Hangzhou Jiuyuan Genetic Biopharmaceutical had annual revenue of 1.37B with 6.35% growth.

Revenue (ttm)
1.31B CNY
Revenue Growth
-1.56%
P/S Ratio
1.62
Revenue / Employee
801.47K CNY
Employees
1,629
Market Cap
2.32B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.37B81.78M6.35%
Dec 31, 20231.29B162.00M14.40%
Dec 31, 20221.13B-181.85M-13.91%
Dec 31, 20211.31B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition